World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
60
Citations
12186
World Ranking
9740
National Ranking
2739

Kirk R. Gustafson publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Kirk R. Gustafson sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 194 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Kirk R. Gustafson D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Kirk R. Gustafson sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 60 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Kirk R. Gustafson is affiliated with the National Institutes of Health in the United States. Their research contributions span multiple fields including biochemistry, genetics and molecular biology, medicine, and chemistry. Within these broad areas, their work focuses on molecular biology, pharmacology, biotechnology, organic chemistry, and cancer research.

The scientist has published extensively on topics related to marine sponges and natural products, microbial natural products and biosynthesis, synthetic organic chemistry methods, chemical synthesis and analysis, plant biochemistry and biosynthesis, synthesis and biological activity, as well as chemical synthesis and alkaloids.

Frequent publication venues for their research include:

  • Journal of Natural Products
  • Organic Letters
  • Molecules
  • Marine Drugs
  • Natural Product Reports

Notable recent papers by Kirk R. Gustafson include:

  • "Sesterterpenoids: chemistry, biology, and biosynthesis," 2020, Natural Product Reports
  • "National Cancer Institute (NCI) Program for Natural Products Discovery: Rapid Isolation and Identification of Biologically Active Natural Products from the NCI Prefractionated Library," 2020, ACS Chemical Biology
  • "Denigrins and Dactylpyrroles, Arylpyrrole Alkaloids from a Dactylia sp. Marine Sponge," 2020, Journal of Natural Products
  • "A Molecular Networking Strategy: High-Throughput Screening and Chemical Analysis of Brazilian Cerrado Plant Extracts against Cancer Cells," 2021, Cells
  • "Recifin A, Initial Example of the Tyr-Lock Peptide Structural Family, Is a Selective Allosteric Inhibitor of Tyrosyl-DNA Phosphodiesterase I," 2020, Journal of the American Chemical Society

The researcher has collaborated frequently with several co-authors, including:

  • Dongdong Wang
  • Barry R. O'Keefe
  • Heidi R. Bokesch
  • Chang-Kwon Kim
  • Wei Jiang

Their work intersects multiple scientific disciplines with an emphasis on natural product chemistry, especially concerning marine-derived compounds and bioactive molecules. This interdisciplinary approach integrates synthetic organic chemistry methods and biological evaluation to explore novel chemical entities with potential applications in pharmacology and cancer research.

Best Publications

  • Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.

    M R Boyd;K R Gustafson;J B McMahon;R H Shoemaker

  • The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.

    Yoel Kashman;Kirk R. Gustafson;Richard W. Fuller;John H. Cardellina

  • AIDS-Antiviral Sulfolipids From Cyanobacteria (Blue-Green Algae)

    Kirk R. Gustafson;John H. Cardellina;Richard W. Fuller;Owen S. Weislow

  • Circulins A and B. Novel human immunodeficiency virus (HIV)-inhibitory macrocyclic peptides from the tropical tree Chassalia parvifolia.

    Kirk R. Gustafson;Raymond C. Sowder;Louis E. Henderson;Ian C. Parsons

  • Solution structure of cyanovirin-N, a potent HIV-inactivating protein

    C A Bewley;K R Gustafson;M R Boyd;D G Covell

  • The guttiferones, HIV-inhibitory benzophenones from Symphonia globulifera, Garcinia livingstonei, Garcinia ovalifolia and Clusia rosea

    Kirk R. Gustafson;John W. Blunt;Murray H.G. Munro;Richard W. Fuller

  • PAPUAMIDES A-D, HIV-INHIBITORY AND CYTOTOXIC DEPSIPEPTIDES FROM THE SPONGES THEONELLA MIRABILIS AND THEONELLA SWINHOEI COLLECTED IN PAPUA NEW GUINEA

    R.W.M. van Soest;P.W. Ford;K.R. Gustafson;T.C. Mc Kee

  • Englerin A, a selective inhibitor of renal cancer cell growth, from Phyllanthus engleri.

    Ranjala Ratnayake;David Covell;Tanya T Ransom;Kirk R Gustafson

  • A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1

    Kirk R. Gustafson;John H. Cardellina;James B. McMahon;Robert J. Gulakowski

  • Potent Anti-Influenza Activity of Cyanovirin-N and Interactions with Viral Hemagglutinin

    Barry R. O'Keefe;Donald F. Smee;Jim A. Turpin;Carrie J. Saucedo

  • Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans

    François Helle;Czeslaw Wychowski;Ngoc Vu-Dac;Kirk R. Gustafson

  • Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis.

    Conan K L Wang;Michelle L Colgrave;Kirk R Gustafson;David C Ireland

  • Isolation and characterization of new anti-HIV and cytotoxic leads from plants, marine, and microbial organisms.

    McKee Tc;Bokesch Hr;McCormick Jl;Rashid Ma

  • Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping.

    Fan Yang;Carole A Bewley;John M Louis;Kirk R Gustafson

  • Anti-HIV cyclotides.

    Kirk R. Gustafson;Tawnya C. McKee;Heidi R. Bokesch

  • Cyclotides as natural anti-HIV agents.

    David C. Ireland;Conan K. L. Wang;Jennifer A. Wilson;Kirk R. Gustafson

  • Marine pharmacology in 2001–2: antitumour and cytotoxic compounds

    Unknown

  • Marine pharmacology in 2000: Antitumor and cytotoxic compounds

    Unknown

  • Isolation and characterization of novel cyclotides from Viola hederaceae : Solution structure and anti-HIV activity of vhl-1, a leaf-specific expressed cyclotide

    Bin Chen;Bin Chen;Michelle L. Colgrave;Norelle L. Daly;K. Johan Rosengren

  • The role of the cyclic peptide backbone in the anti-HIV activity of the cyclotide kalata B1.

    Norelle L. Daly;Kirk R. Gustafson;David J. Craik

  • Neamphamide A, a new HIV-inhibitory depsipeptide from the Papua New Guinea marine sponge Neamphius huxleyi.

    Naoya Oku;Kirk R. Gustafson;Laura K. Cartner;Jennifer A. Wilson

  • Solution structure by NMR of circulin A: a macrocyclic knotted peptide having anti-HIV activity

    Norelle L Daly;Anita Koltay;Kirk R Gustafson;Michael R Boyd

  • New circulin macrocyclic polypeptides from Chassalia parvifolia.

    Kirk R. Gustafson;Linda K. Walton;Raymond C. Sowder;Donald G. Johnson

Frequent Co-Authors

John H. Cardellina
John H. Cardellina Montana State University
James B. McMahon
James B. McMahon National Institutes of Health
Lewis K. Pannell
Lewis K. Pannell National Institutes of Health
Michael R. Boyd
Michael R. Boyd University of South Alabama
Michael R. Boyd
Michael R. Boyd National Cancer Institute
John A. Beutler
John A. Beutler National Institutes of Health
Yoel Kashman
Yoel Kashman Tel Aviv University
Barry R. O'Keefe
Barry R. O'Keefe National Institutes of Health
Nancy H. Colburn
Nancy H. Colburn National Institutes of Health
Robert H. Shoemaker
Robert H. Shoemaker National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their education beyond Chemistry, there are various related online degree options that open doors to diverse career paths. Many students consider the cost of education carefully, so understanding criminal justice degree tuition is an important factor when choosing a program. Affordable online programs can provide valuable skills without a hefty financial burden.

Entry-level opportunities often begin with foundational studies like an online criminal justice associate degree programs, which offer a direct pathway into law enforcement or security sectors. Similarly, professions such as paralegals require specialized knowledge that can be gained through a paralegal associate degree, blending legal expertise with administrative skills.

For those leaning towards the pharmaceutical industry, understanding how much do pharmaceutical reps make can provide insight into lucrative job prospects. These roles often benefit from a chemistry background combined with sales acumen, highlighting the versatility of scientific education.

Exploring these online degrees and career pathways allows Chemistry graduates and enthusiasts to broaden their horizons and find rewarding professions tailored to their interests and strengths.

Best Scientists Citing Kirk R. Gustafson

Trending Scientists

Recently Published Articles